Error: Could not add to watchlist. X

NewLink Genetics Corp

+ Watchlist
4NX:GR
Frankfurt
39.92
EUR
0.72
1.77%
As of 14:19:40 ET on 07/07/2015.
Open
40.64
Day Range
39.56 - 41.27
Volume
0
Previous Close
40.64
52Wk Range
13.67 - 54.39
1 Yr Return
117.06%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (b EUR)
1.143
Shares Outstanding (m)
28.643
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
NewLink Genetics Corporation is a biopharmaceutical company. The Company develops and commercializes biologic and small-molecule immunotherapy products intended to treat a wide range of cancers. NewLink's products are designed to harness components of the patient's immune system to fight cancer either alone or in combination with other treatment regimens.
ADDRESS
2503 South Loop Drive
Suite 5100
Ames, IA 50010
United States
PHONE
1-515-296-5555
  • Charles J Link
    Chairman/CEO/Chief Scientific Ofcr
  • Nicholas N Vahanian
    President/Chief Medical Ofcr
  • John B Henneman "Jack"
    Exec VP/CFO/Secretary
  • Brian Wiley
    VP:Business Development
Show More